SureAdhere

SureAdhere is a patient engagement platform developed by Dimagi that enables secure, video-based Directly Observed Therapy (VDOT). It allows patients to take their medication remotely while maintaining adherence to complex treatment regimens. Designed for public health, behavioral health, and clinical trials, SureAdhere improves outcomes, reduces provider burden, and supports scalable, personalized care across diverse healthcare settings.

Features

• Video Directly Observed Therapy (VDOT)
• Dose-by-dose tracking and side-effect logging
• Real-time adherence analytics
• Secure in-app messaging and live video visits
• Offline functionality for low-connectivity environments
• Integration with EHRs, EMRs, and remote monitoring devices
• HIPAA, GDPR, CFR Part 11, and SOC 2 compliance
• Configurable dose reminders and treatment calendars
• Multi-modal adherence options (video, in-person, MERM devices)
• Provider dashboard for triage and follow-up

Capabilities

• Remote medication adherence monitoring
• Personalized treatment support for TB, HIV, Hepatitis C, and opioid use disorder
• Scalable program capacity for high-need patient prioritization
• Centralized data capture and workflow optimization
• Support for clinical trials with participant engagement tools
• Secure communication between patients and providers
• Evidence-based platform validated by CDC and WHO guidelines
• Customizable treatment experiences across care delivery models

Benefits

• Reduces need for in-person visits, saving time and resources
• Enhances patient autonomy and privacy
• Improves treatment adherence and health outcomes
• Streamlines operations and reduces administrative burden
• Enables continuity of care in remote or underserved areas
• Increases provider efficiency and satisfaction
• Trusted by over 350 healthcare programs in 18 countries
• Proven effectiveness through peer-reviewed research and global adoption